Eleonora Dimitrova
Eleonora Dimitrova
Потвърден имейл адрес: mu-varna.bg
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer
MP Petrova, MI Eneva, JI Arabadjiev, NV Conev, EG Dimitrova, ...
Bioscience trends 14 (1), 48-55, 2020
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer
MP Petrova, IS Donev, MA Radanova, MI Eneva, EG Dimitrova, ...
Clinical & Experimental Immunology 202 (3), 353-362, 2020
RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer
NV Conev, YK Kashlov, EG Dimitrova, YK Kashlov, MK Bogdanova, ...
Clinical and Investigative Medicine 42 (1), E31-E38, 2019
Association between serum CK-18 levels and the degree of liver damage in fructose-induced metabolic syndrome
K Bratoeva, S Nikolova, A Merdzhanova, GS Stoyanov, E Dimitrova, ...
Metabolic syndrome and related disorders 16 (7), 350-357, 2018
1698P The presence of COVID-19 makes more cancer patients distressed and time perception may distinguish them
NV Conev, M Petrova, E Dimitrova, K Zhelev, ZI Zahariev, K Nikolov, ...
Annals of Oncology 31, S1002, 2020
Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's …
EG Dimitrova, BG Chaushev, NV Conev, JK Kashlov, AK Zlatarov, ...
Bioscience trends 11 (2), 221-228, 2017
KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
M Radanova, G Mihaylova, GS Stoyanov, V Draganova, A Zlatarov, ...
International Journal of Molecular Sciences 24 (16), 12753, 2023
Time perception as a novel ultra-short screening tool for distress in cancer patients.
NV Conev, I Donev, D Stoyanov, M Ivanova, E Dimitrova, A Yanchev
Journal of Clinical Oncology 36 (15_suppl), e22123-e22123, 2018
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies
G Todorov, C Bachvarov, G Valchev, N Kolev, A Tonev, V Ignatov, ...
Varna Medical Forum 7 (1), 11-14, 2018
Embolization of bronchial arteries in cases of life-threatening bleeding
G Todorov, C Bachvarov, G Valchev, R Popova, A Antonov, S Sirakov, ...
Heart-Lung (Varna) 21 (1-2), 45-49, 2015
Sensory profiling of dairy starch dessert creams enhanced with various types and concentrations of tahini
M Dzhivoderova-Zarcheva, K Nikovska, S Ivanova, E Dimitrova
International Journal of Gastronomy and Food Science 36, 100925, 2024
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting
R Gencheva, M Petrova, P Kraleva, S Hadjidekova, M Radanova, ...
Cancer Reports 7 (2), e1966, 2024
68 A pictorial view on false positive findings of Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable …
MD Borislav Chaushev, R Marinov, V Nikolov, MD Georgi Todorov, ...
Hellenic Journal of Nuclear Medicine, 2024
Patient resilience and distress level prior to chemotherapy based on time estimation.
P Kraleva, M Petrova, T Popov, NV Conev, E Dimitrova, RK Ruseva, ...
Journal of Clinical Oncology 41 (16_suppl), e24184-e24184, 2023
PI3KCA mutation prevalence and outcome among patients with metastatic breast cancer in Bulgaria treated with first-line endocrine therapy.
R Gencheva, S Hadjidekova, M Petrova, D Krustev, P Kraleva, ...
Journal of Clinical Oncology 41 (16_suppl), e13005-e13005, 2023
P-216 Serum levels of HMGB1 might have a predictive role for neoadjuvant radiotherapy combined with chemotherapy in rectal cancer patients
T Radeva-Petkova, E Encheva, G Mihaylova, D Palamudova, S Bilyukova, ...
Annals of Oncology 33, S326, 2022
Impact of travel burden on overall survival in patients with lung cancer.
DS Stoyanov, I Tonev, E Dimitrova, T Panayotova, R Manev, I Donev, ...
Journal of Clinical Oncology 40 (16_suppl), 6522-6522, 2022
Key Apoptosis Signaling Pathways In Malignant Diseases
T Panayotova, D Stoyanov, R Manev, M Maneva, B Stefanova, ...
Varna Medical Forum 10 (3), 9-13, 2021
High neutrophil to lymphocyte ratio as a predictor for hyperprogressive disease in patients with metastatic non-small cell lung cancer treated with pembrolizumab as a second line.
M Petrova, M Eneva, JI Arabadjiev, NV Conev, E Dimitrova, KD Koynov, ...
Journal of Clinical Oncology 38 (15_suppl), e21546-e21546, 2020
Dynamic of time estimation and its relation with levels of distress.
NV Conev, M Ivanova, E Dimitrova, A Yanchev, I Donev
Journal of Clinical Oncology 38 (15_suppl), e19091-e19091, 2020
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20